Anna Hilser

Anna Hilser is a Senior Scientist in Biology at Bicycle Therapeutics, with a strong background in molecular pharmacology, where significant contributions have been made to the internal oncology pipeline. Prior experience includes a PhD focused on pharmacological validation of GIPR allosteric modulators at the University of Cambridge, alongside participation in the EnterpriseTECH program and winning the biotechnology Young Entrepreneurs Scheme competition. Additional internships and research roles have included projects on adenosine receptors and biased signaling of GLP-1R. Anna holds a PhD and a BA in Pharmacology from the University of Cambridge and has attended summer courses at Harvard and Yale universities.